Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Cosmo N.V. CMOPF

Full chart Compare

Set alert

73.73 USD 0.00 (+0.00%)

At closeNov 10, 2026, 4:00 PM EST

69.75 Day range 69.75

59.02 52-week range 169.90

YTD: -44.56%
1 year: -9.85%

News

3 weeks ago seekingalpha.com Cosmo N.V. (CMOPF) Discusses Positive Phase 2 Results and Differentiation of Rifamycin 1% Gel in Ulcerative Colitis and Proctitis Transcript Cosmo N.V. (CMOPF) Discusses Positive Phase 2 Results and Differentiation of Rifamycin 1% Gel in Ulcerative Colitis and Proctitis Transcript
3 months ago seekingalpha.com Cosmo N.V. (CMOPF) Q2 2026 Earnings Call Transcript Cosmo N.V. (CMOPF) Q2 2026 Earnings Call Transcript
8 months ago seekingalpha.com Cosmo Pharmaceuticals N.V. (CMOPF) Q4 2025 Earnings Call Transcript Cosmo Pharmaceuticals N.V. (CMOPF) Q4 2025 Earnings Call Transcript
10 months ago defenseworld.net Cosmo Pharmaceuticals (OTC:CMOPF) Stock Price Up 1.1% – Here’s What Happened Cosmo Pharmaceuticals (OTC: CMOPF - Get Free Report)'s stock price was up 1.1% during trading on Friday. The stock traded as high as C$135.00 and last traded at C$135.00. Approximately 558 shares…
11 months ago gurufocus.com The Hair-Loss Cure That Just Sent This Stock Exploding 24%--Is Big Pharma Paying Attention? Cosmo Pharmaceuticals (CMOPF) just delivered the kind of data that can shift an entire market narrative. After releasing late-stage results for its experimental